NGM Biopharmaceuticals, Inc.

NGM · NASDAQ
Analyze with AI
12/31/2023
9/30/2023
6/30/2023
3/31/2023
Assets
Cash & Equivalents$58,815$51,476$53,271$67,549
Short-Term Investments$88,369$114,569$140,273$163,455
Receivables$58$0$736$1,257
Inventory$0$0$1,499$1,499
Other Curr. Assets$9,202$7,994$8,623$8,769
Total Curr. Assets$156,444$177,038$204,402$242,529
Property Plant & Equip (Net)$7,033$7,819$8,827$9,552
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$2,455$2,455$2,455$2,455
Tax Assets$0$0$0$0
Other NC Assets$2,936$4,838$4,860$4,301
Total NC Assets$12,424$15,112$16,142$16,308
Other Assets$0$0$0$0
Total Assets$168,868$192,150$220,544$258,837
Liabilities
Payables$2,982$4,690$5,855$13,293
Short-Term Debt$0$1,381$2,751$4,073
Tax Payable$0$0$0$0
Deferred Revenue$0$107$689$376
Other Curr. Liab.$17,099$16,167$19,128$20,161
Total Curr. Liab.$20,081$22,345$28,423$37,903
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$149$0$0$0
Total NC Liab.$149$0$0$17,366
Other Liabilities$0$0$0-$17,366
Cap. Leases$0$0$0$0
Total Liabilities$20,230$22,345$28,423$37,903
Equity
Pref Stock$0$0$0$0
Common Stock$83$83$83$82
Retained Earnings-$724,008-$696,338-$667,541-$629,280
AOCI$18-$78-$149-$97
Other Equity$872,545$866,138$859,728$850,229
Total Equity$148,638$169,805$192,121$220,934
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$168,868$192,150$220,544$258,837
Net Debt-$58,815-$50,095-$50,520-$63,476